黄色视频不卡_午夜福利免费观看在线_亚洲国产精品999在线_欧美绝顶高潮抽搐喷水_久久精品成人免费网站_晚上一个人看的免费电影_国产又色又爽无遮挡免费看_成人国产av品久久久

    1. <dd id="lgp98"></dd>
      • <dd id="lgp98"></dd>
        1. 上海源葉生物科技有限公司

          主營產(chǎn)品: S30260異硫氰酸胍,30259鹽酸胍,嗜熱菌蛋白酶

          14

          聯(lián)系電話

          15921386130

          您現(xiàn)在的位置: 上海源葉生物科技有限公司>>小分子化合物>>小分子抑制劑>> S81189

          公司信息

          聯(lián)人:
          何小姐
          話:
          86-021-61559134
          機(jī):
          15921386130
          真:
          86-021-55068248
          址:
          上海市松江區(qū)長塔路465號(hào)6幢
          編:
          200433
          網(wǎng)址:
          www.shyuanye.com
          鋪:
          http://facexiu.com/st191837/
          給他留言
          S81189
          S81189
          參考價(jià) 面議
          具體成交價(jià)以合同協(xié)議為準(zhǔn)
          • 型號(hào)
          • 品牌
          • 廠商性質(zhì) 生產(chǎn)商
          • 所在地

          更新時(shí)間:2024-07-02 20:18:53瀏覽次數(shù):155

          聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!

          【簡單介紹】
          提示:詳情請(qǐng)下載說明書
          • 提示:詳情請(qǐng)下載說明書。
          • 產(chǎn)品描述:

             Onvansertib, also know as NMS-P937, PCM-075 and NMS1286937, is a n orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor NMS-1286937 selectively inhibits PLK1, inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells. PLK1 inhibition may result in the inhibition of proliferation in PLK1-overexpressing tumor cells. PLK1 is a serine/threonine protein kinase crucial in the regulation of mitosis.

          • 靶點(diǎn): PLK1;MELK;CK2;FLT3
          • 體外研究: NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with IC50 of 2 nM. NMS-1286937 also shows inhibitory activities against FLT3, MELK, and CK2, with IC50s of 510, 744, and 826 nM, respectively. NMS-P937 possesses a pure ATP competitive mechanism with a reversible dissociation and no time dependency. NMS-P937 (10 μM) is selective with a marginal activity of 48% and 40% inhibition on PLK2 and PLK3, respectively. NMS-P937 shows antiproliferative activity against a panel of 137 cell lines, with IC50 values of below 100 nM for 60 of 137 cell lines and higher than 1 μM for only 9 of 137 cell lines. NMS-P937 shows cytotoxic activity against AmL-NS8 cells with IC50 of 36 nM.
          • 體內(nèi)研究: NMS-1286937 (45 mg/kg, i.v.) shows a good tumor growth inhibition with acceptable and reversible body weight loss in CD1 nu/nu mice xenografted with human HCT116 colon adenocarcinoma cells. NMS-1286937 (60 mg/kg, p.o.) also inhibits the growth of tumor on HCT116 xenograft model. NMS-P937 (45 mg/kg, i.v.or 60 mg/kg, p.o) inhibits tumor growth to a comparable degree (TGI, 83% and 79% intravenously and orally, respectively) in HCT116-bearing mice. The combination of NMS-P937 (120 mg/kg given for 4 cycles of 2 consecutive days with 10-day rest) and cytarabine (75 mg/kg for 4 cycles of 5 consecutive days with 7-day rest) in the disseminated leukemia model AmL-PS is well tolerated and clearly showed increased mice survival. NMS-P937 (60 mg/kg bid os per day over 2 days with a 5 day rest) shows good efficacy compared to standard therapies, with a significant increase in median survival time (MST) in the established disease setting.
          • 參考文獻(xiàn):
            1. Beria I, et al. NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor. Bioorg Med Chem Lett. 2011 May 15;21(10):2969-74.
            2. Valsasina B, et al. NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies. Mol Cancer Ther. 2012 Apr;11(4):1006-16.
            3. Casolaro A, et al. The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia. PLoS One. 2013;8(3):e58424.
          • 溶解度: DMSO:  21  mg/mL
          • 保存條件: -20℃
          • 配置溶液濃度參考:
            1mg 5mg 10mg
            1 mM 1.878 ml 9.389 ml 18.779 ml
            5 mM 0.376 ml 1.878 ml 3.756 ml
            10 mM 0.188 ml 0.939 ml 1.878 ml
            50 mM 0.038 ml 0.188 ml 0.376 ml
          • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的性,僅供客戶參考交流研究之用。
          該公司的其它相關(guān)產(chǎn)品查看所有產(chǎn)品 >>


          產(chǎn)品對(duì)比 產(chǎn)品對(duì)比 二維碼 在線交流

          掃一掃訪問手機(jī)商鋪

          對(duì)比框

          在線留言
          太和县| 柏乡县| 安徽省| 安丘市| 延寿县| 莱阳市| 定日县| 同心县| 会泽县| 拉萨市| 历史| 永清县| 枝江市| 厦门市| 许昌市| 南澳县| 北海市| 鄂伦春自治旗| 铅山县| 旌德县| 黄山市| 二连浩特市| 宁海县| 岳阳县| 大邑县| 吐鲁番市| 轮台县| 分宜县| 宁海县| 仲巴县| 淮安市| 和政县| 扶绥县| 兴义市| 东光县| 蒙山县| 凤阳县| 永济市| 鄂尔多斯市| 来宾市| 金坛市|